FDA Approves New Gadolinium-Based MRI Agent

The MRI contrast agent, already on the market in dozens of other countries, helps radiologists visualize abnormalities of the central nervous system.
FDA Approvals

http://www.medscape.com/viewarticle/781144?src=rss

Sent with MobileRSS for iPhone

Júlio Leonardo B. Pereira

Phone: (+1) 424-2301706

Linkedin:http://www.linkedin.com/in/juliommais 

Site: www.neurocirurgiabr.com